LINNEA TARTER: Open Payments
NPI 1508522889 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,174 in 79 payments from 10 companies in 2025. Trend: 2023 $223 · 2024 $300 · 2025 $1,174
Food & beverage: $1,174
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $341 |
| Axsome Therapeutics, Inc. | 12 | $223 |
| Alkermes, Inc. | 15 | $209 |
| AstraZeneca Pharmaceuticals LP | 3 | $137 |
| Vanda Pharmaceuticals Inc. | 5 | $100 |
| PFIZER INC. | 3 | $58 |
| Averitas Pharma Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Cipher Pharmaceuticals US LLC | 1 | $17 |
| Amgen Inc. | 1 | $17 |
Products named: Auvelity, QULIPTA, LYBALVI, AIRSUPRA, FANAPT, VRAYLAR, ARISTADA, UBRELVY.
Industry payments across KY — which companies pay providers there.
